Colorectal cancer (CRC) is the third most common cause of cancer-related death in the
United States. Early identification and treatment of pre-cancerous colorectal lesions, or node …

Detection of colorectal cancer at an early stage may significantly decrease mortality from the
disease. The current screening test of colonoscopy is of high efficacy, but its acceptance in …

Colorectal cancer (CRC) is a leading cause of cancer related deaths worldwide, and late
stages (III-IV) in particular have low 5-year survival rates. Stage shifting by CRC screening …

Colorectal cancer (CRC) is the second leading cause of cancer death worldwide that is
attributed to gradual long‐term accumulation of both genetic and epigenetic changes. To …

Purpose Methylated cell-free DNA in liquid biopsies are promising non-invasive biomarkers
for colorectal cancer (CRC). Optimal markers would have high sensitivity and specificity for …

Colorectal cancer (CRC) is one of the most prevalent malignancies in the world. CRC-
associated morbidity and mortality is continuously increasing, in part due to a lack of early …

Simple Summary High-performance, non-invasive screening is a requirement in colorectal
cancer (CRC) as early detection is a key in reducing disease-related mortality in CRC …

DNA methylation biomarkers for noninvasive diagnosis of colorectal cancer (CRC) and
precursor lesions have been extensively studied. Different panels have been reported …

Aberrant DNA methylation is frequently detected in gastrointestinal tumors, and can
therefore potentially be used to screen, diagnose, prognosticate, and predict colorectal …

Background Colorectal cancer (CRC) is one of the most common cancers in the western
world. Screening is an efficient method of reducing cancer-related mortality. Molecular …